ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMID 18384413)

Published in Cephalalgia on March 31, 2008

Authors

S Colnaghi1, M Versino, E Marchioni, A Pichiecchio, S Bastianello, V Cosi, G Nappi

Author Affiliations

1: Department of Neurology, University of Pavia; Department of Neuro-Otology and Neuro-Ophthalmology, IRCCS Neurological Institute C. Mondino Foundation, Pavia, Italy. si.co@libero.it

Articles by these authors

New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97

Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke (1999) 2.97

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86

Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77

Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33

Reduced habituation of trigeminal reflexes in patients with episodic cluster headache during cluster period. Cephalalgia (2008) 2.18

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler (2009) 1.98

Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia (2004) 1.83

Cervicogenic headache: evaluation of the original diagnostic criteria. Cephalalgia (2001) 1.81

Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke (1999) 1.80

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia (2004) 1.79

Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology (1996) 1.74

Ascending aorta-abdominal aorta bypass: indications, technique, and report of 12 patients. Ann Thorac Surg (1977) 1.73

Headache attributed to infection: observations on the IHS classification (ICHD-II). Cephalalgia (2006) 1.69

Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68

Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis. J Neurol Sci (2001) 1.66

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65

Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol (2000) 1.65

Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia (2013) 1.55

International Headache Society classification: interobserver reliability in the diagnosis of primary headaches. Cephalalgia (1994) 1.55

Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke (1999) 1.55

Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology (2006) 1.51

Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol (1992) 1.50

Reversibility of vigabratin-induced visual-field defect. Lancet (1999) 1.46

What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS? Mult Scler (2008) 1.45

Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. J Neurol Sci (2007) 1.44

Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels. Cephalalgia (2003) 1.43

Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia (2010) 1.43

Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology (2001) 1.42

Indomethacin increases the effect of isosorbide dinitrate on cerebral hemodynamic in migraine patients: pathogenetic and therapeutic implications. Cephalalgia (1998) 1.41

Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia (2003) 1.39

Hand weakness from a precentral gyrus infarct with intermittent hypotension. Neurology (2001) 1.39

The association of menstrual migraine with the premenstrual syndrome. Cephalalgia (1993) 1.39

Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician. J Neurol Sci (2000) 1.38

Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia (2006) 1.34

Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol (1995) 1.24

Genetic heterogeneity in Italian families with familial hemiplegic migraine. Neurology (1999) 1.23

An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology (1996) 1.20

Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology (2005) 1.19

Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol (2011) 1.18

Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke (1988) 1.17

Psychiatric comorbidity in chronic daily headache. Cephalalgia (1998) 1.16

Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med (2000) 1.15

Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke (1989) 1.14

Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol (2009) 1.14

Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol (1997) 1.12

Guillain-Barré syndrome. Neurol Sci (2006) 1.12

Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia (2010) 1.11

Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia (2005) 1.11

Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia (2004) 1.11

Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Neurodegener Dis (2008) 1.10

Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest (1999) 1.10

Poor sleep in adolescents: a study of 869 17-year-old Italian secondary school students. J Sleep Res (1997) 1.09

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol (2001) 1.09

Cluster headache--clinical findings in 180 patients. Cephalalgia (1983) 1.08

Intracranial actinomycosis in juvenile patients. Case report and review of the literature. Childs Nerv Syst (1998) 1.07

SPG3A: An additional family carrying a new atlastin mutation. Neurology (2002) 1.07

[Pourfour du Petit syndrome and intracranial aneurysms (author's transl)]. Riv Patol Nerv Ment (1977) 1.06

Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease. Exp Neurol (2004) 1.06

Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. Neurol Sci (2004) 1.05

Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache (1990) 1.03

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Mult Scler (2011) 1.02

A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet (2002) 1.01

Clinical aspects of fatigue in multiple sclerosis. Funct Neurol (1998) 1.01

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain (1998) 1.01

Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia (2006) 1.00

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler (2004) 1.00

The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia (2000) 1.00

Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr (2003) 0.99

Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia (2008) 0.99

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.99

A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia (2006) 0.99

Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia (2008) 0.99

A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol (1990) 0.99

Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia (1999) 0.99

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99

Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy. J Neurol Sci (2006) 0.98

Transcranial Doppler in acute hemispheric brain infarction. Neurology (1991) 0.98

Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia (2006) 0.98

BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease. Eur J Neurol (2009) 0.98

Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia (2002) 0.97

[Polyneuritis caused by industrial glues. Clinical and electromylgraphic study]. Riv Neurol (1972) 0.96

Nutrition and cognitive deficit in the elderly: a population study. Eur J Clin Nutr (2001) 0.96

A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci (2005) 0.96

Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metab (1982) 0.96

Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci (1991) 0.96

Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology (2004) 0.95

Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord (2003) 0.95

Dietary and nutritional patterns in an elderly rural population in Northern and Southern Italy: (I). A cluster analysis of food consumption. Eur J Clin Nutr (2003) 0.95

Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis (1991) 0.95

Two patients with COMT inhibitor-induced hepatic dysfunction and UGT1A9 genetic polymorphism. Neurology (2005) 0.95

Single high-dose steroid treatment in episodic cluster headache. Cephalalgia (2005) 0.94

Epileptic skew deviation. Neurology (1998) 0.93

Quantitative study of mitochondrial complex I in platelets of parkinsonian patients. Mov Disord (1998) 0.93

The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS. J Neurol (2003) 0.93

Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol (1995) 0.93

Memory impairment in Cushing's disease. Acta Neurol Scand (1993) 0.93